PyroGenesis Announces Contract for Second Phase Lab Scale Testing Program with HPQ Silicon Resources

Cleantech Investing

PyroGenesis (TSXV:PYR) has announced it has signed a contract with HPQ Silicon Resources for $170,000 where PyroGenesis will provide a second phase of Process Characterization Testing using a new version of the lab scale PUREVAP Quartz Reduction Reactor. As quoted in the press release: The purpose of the Testing is to build upon the bench …

PyroGenesis (TSXV:PYR) has announced it has signed a contract with HPQ Silicon Resources for $170,000 where PyroGenesis will provide a second phase of Process Characterization Testing using a new version of the lab scale PUREVAP Quartz Reduction Reactor.
As quoted in the press release:

The purpose of the Testing is to build upon the bench scale success made to date and to push the design of the lab scale Reactor to a point that will allow it to operate in a semi-batch mode to produce silicon (Si) samples. The Testing will use higher purity feedstock (99.5% SiO2.) with a goal of producing at least 5N (99.999% Si) Solar Grade Silicon Metal at lab scale.
This Testing program will take place over the next several months, and will be in conjunction with the delivery of the pilot plant Reactor scheduled for October 2017. The objectives of these metallurgical tests will be, amongst others, to: (i) generate and collect data that can be used for the scale-up of the lab scale Reactor and ultimately, for the commercial scale-up of the PUREVAP™ process; and (ii) to continue testing different purification alternatives.
PyroGenesis will provide HPQ with samples for third party independent purity validation as well as a milestones report and final report summarizing the results and analysis.
“We are eager to start this additional testing phase,” said Pierre Carabin, Chief Technology Officer of PyroGenesis. “This new testing will allow us to validate the design of pilot plant Reactor and to further improve the product purity.”

Click here to read the full press release.

The Conversation (0)
×